Evaluation of appropriate transmission-based precautions for non-SARS-CoV-2 respiratory viruses

Cassandra L Falk; Lisa E Dumkow; Abigail C Geyer; Kyle J Schmidt; Nnaemeka E Egwuatu; Jennifer M Langholz; Andrew P Jameson

doi:10.1017/ash.2023.472

Evaluation of appropriate transmission-based precautions for non-SARS-CoV-2 respiratory viruses

Antimicrob Steward Healthc Epidemiol. 2023 Oct 31;3(1):e193. doi: 10.1017/ash.2023.472. eCollection 2023.

Authors

Cassandra L Falk¹, Lisa E Dumkow¹, Abigail C Geyer¹, Kyle J Schmidt^{1

2}, Nnaemeka E Egwuatu³, Jennifer M Langholz⁴, Andrew P Jameson^{3

5}

Affiliations

¹ Department of Pharmacy, Trinity Health Grand Rapids, Grand Rapids, MI, USA.
² Ferris State University, College of Pharmacy, Grand Rapids, MI, USA.
³ Division of Infectious Disease, Trinity Health Grand Rapids, Grand Rapids, MI, USA.
⁴ Division of Infection Control, Trinity Health Grand Rapids, Grand Rapids, MI, USA.
⁵ Department of Medicine, Michigan State College of Human Medicine, Grand Rapids, MI, USA.

Abstract

Appropriateness of transmission-based precautions after positive result for a non-SARS-CoV-2 virus was evaluated. Most patients (77.2%) lacked appropriate precautions within 3 hours of virus detection; 36.9% remained without appropriate precautions during their stay. With recent cessation of universal masking, adherence to infection control best practices is needed to optimize safety.